<!DOCTYPE html><html lang="en"><head><title>Help for package adaptIVPT</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {adaptIVPT}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#adaptIVPT'><p>adaptIVPT: Adaptive Bioequivalence Design for In-Vitro Permeation Tests for Pharmacokinetics with Mixed Scaling Approach</p></a></li>
<li><a href='#msabe'><p>Run the mixed scaling approach in bioequivalence (BE) studies</p></a></li>
<li><a href='#prms'><p>Compute the passing rate for the mixed scaling approach in bioequivalence (BE) studies</p></a></li>
<li><a href='#PRsurface'><p>Plot the passing-rate curve and the passing-rate surface in IVPT</p></a></li>
<li><a href='#rss'><p>Reestimate the sample size for the adaptive design in bioequivalence (BE) studies using mixed criterion.</p></a></li>
<li><a href='#summary.msabe'><p>'summary' method for class &quot;'msabe'&quot;</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table role='presentation'>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Adaptive Bioequivalence Design for In-Vitro Permeation Tests</td>
</tr>
<tr>
<td>Version:</td>
<td>1.1.0</td>
</tr>
<tr>
<td>Date:</td>
<td>2024-01-14</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Daeyoung Lim &lt;Daeyoung.Lim@fda.hhs.gov&gt;</td>
</tr>
<tr>
<td>Description:</td>
<td>Contains functions carrying out adaptive procedures using mixed scaling approach to establish bioequivalence for in-vitro permeation test (IVPT) data. Currently, the package provides procedures based on parallel replicate design and balanced data, according to the U.S. Food and Drug Administration's "Draft Guidance on Acyclovir" <a href="https://www.accessdata.fda.gov/drugsatfda_docs/psg/Acyclovir_topical%20cream_RLD%2021478_RV12-16.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/psg/Acyclovir_topical%20cream_RLD%2021478_RV12-16.pdf</a>. Potvin et al. (2008) &lt;<a href="https://doi.org/10.1002%2Fpst.294">doi:10.1002/pst.294</a>&gt; provides the basis for our adaptive design (see Method B). For a comprehensive overview of the method, refer to Lim et al. (2023) &lt;<a href="https://doi.org/10.1002%2Fpst.2333">doi:10.1002/pst.2333</a>&gt;. This package reflects the views of the authors and should not be construed to represent the views or policies of the U.S. Food and Drug Administration.</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-3">GPL (&ge; 3)</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>LazyLoad:</td>
<td>yes</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>7.2.1</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>yes</td>
</tr>
<tr>
<td>Imports:</td>
<td>Rcpp, rgl</td>
</tr>
<tr>
<td>Depends:</td>
<td>R (&ge; 3.4)</td>
</tr>
<tr>
<td>LinkingTo:</td>
<td>Rcpp, RcppArmadillo, RcppProgress</td>
</tr>
<tr>
<td>Suggests:</td>
<td>knitr, rmarkdown</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2024-01-23 18:05:44 UTC; daeyounglim</td>
</tr>
<tr>
<td>Author:</td>
<td>Daeyoung Lim [aut, cre],
  Elena Rantou [ctb],
  Jessica Kim [ctb],
  Sungwoo Choi [ctb],
  Nam Hee Choi [ctb],
  Stella Grosser [ctb]</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2024-01-26 20:00:03 UTC</td>
</tr>
</table>
<hr>
<h2 id='adaptIVPT'>adaptIVPT: Adaptive Bioequivalence Design for In-Vitro Permeation Tests for Pharmacokinetics with Mixed Scaling Approach</h2><span id='topic+adaptIVPT'></span>

<h3>Description</h3>

<p>This package helps design and analyze adaptive bioequivalence studies. Main functions are <code>msabe</code>, <code>rss</code>, <code>prms</code>, and <code>PRsurface</code>.
</p>

<hr>
<h2 id='msabe'>Run the mixed scaling approach in bioequivalence (BE) studies</h2><span id='topic+msabe'></span>

<h3>Description</h3>

<p>This function runs hypothesis testing for bioequivalence using the mixed criterion
</p>


<h3>Usage</h3>

<pre><code class='language-R'>msabe(Test, Reference, params = list())
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="msabe_+3A_test">Test</code></td>
<td>
<p>An n-by-r matrix of test product data. <code>n</code> is the number of donors and <code>r</code> is the number of skin section replicates.</p>
</td></tr>
<tr><td><code id="msabe_+3A_reference">Reference</code></td>
<td>
<p>An n-by-r matrix of reference product data.</p>
</td></tr>
<tr><td><code id="msabe_+3A_params">params</code></td>
<td>
<p>(Optional) The list of tuning parameters for running the test.
</p>

<ul>
<li> <p><code>sigma_W0</code> - A regulatory constant set by the FDA. Defaults to 0.25.
</p>
</li>
<li> <p><code>m</code> - Another regulatory constant that determines the bounds within which the estimated GMR should fall for bioequivalence to be established. Defaults to 1.25, representing 80-125% average BE limits, which is the FDA recommendation.
</p>
</li>
<li> <p><code>sig_level</code> - The significance level (alpha-level).
</p>
</li></ul>
</td></tr>
</table>


<h3>Value</h3>

<p>A list of lists
</p>

<ul>
<li> <p><code>parameters</code> - A list of true parameter settings.
</p>
</li>
<li> <p><code>fout</code> - The test result and related estimators.
</p>
</li>
<li> <p><code>runtime</code> - The total elapsed time charged for the execution of the program.
</p>
</li></ul>



<h3>Author(s)</h3>

<p>Daeyoung Lim, <a href="mailto:daeyoung.lim@uconn.edu">daeyoung.lim@uconn.edu</a>
</p>


<h3>References</h3>

<p>Davit, B. M., Chen, M. L., Conner, D. P., Haidar, S. H., Kim, S., Lee, C. H., Lionberger, R. A., Makhlouf, F. T., Nwakama, P. E., Patel, D. T., Schuirmann, D. J., &amp; Yu, L. X. (2012). Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. The AAPS journal, 14(4), 915-924.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>n &lt;- 6
r &lt;- 3
Test &lt;- matrix(runif(n*r), nrow = n, ncol = r)
Reference &lt;- matrix(runif(n*r), nrow = n, ncol = r)
out &lt;- msabe(Test, Reference)

</code></pre>

<hr>
<h2 id='prms'>Compute the passing rate for the mixed scaling approach in bioequivalence (BE) studies</h2><span id='topic+prms'></span>

<h3>Description</h3>

<p>This function runs Monte Carlo simulations to compute the passing rate (PR) of the mixed scaling (MS) approach.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>prms(n, r, params = list(), nsim = 1000, ncores = NULL)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="prms_+3A_n">n</code></td>
<td>
<p>The number of donors in each simulation.</p>
</td></tr>
<tr><td><code id="prms_+3A_r">r</code></td>
<td>
<p>The number of replicates from each donor for each simulated dataset.</p>
</td></tr>
<tr><td><code id="prms_+3A_params">params</code></td>
<td>
<p>(Optional) The list of true parameters to be assumed in data generation.
</p>

<ul>
<li> <p><code>sigma_W0</code> - A regulatory constant set by the FDA. Defaults to 0.25.
</p>
</li>
<li> <p><code>sigma_WT</code> - The true standard deviation of the test formulation population.
</p>
</li>
<li> <p><code>sigma_WR</code> - The true standard deviation of the reference formulation population.
</p>
</li>
<li> <p><code>GMR</code> - The geometric mean ratio of the test and reference values of the pharmacokinetic measures (e.g., Jmax or AUC). If the test-formulation measure is greater than that of the reference formulation, then GMR is typically set to 1.05, which is the initial value of this function. If the reference-formulation measure is bigger, then GMR is typically 0.95. Defaults to 0.95.
</p>
</li>
<li> <p><code>m</code> - Another regulatory constant that determines the bounds within which the estimated GMR should fall for bioequivalence to be established. Defaults to 1.25, representing 80-125% average BE limits, which is the FDA recommendation.
</p>
</li>
<li> <p><code>sig_level</code> - The significance level (alpha-level). Defaults to 0.05.
</p>
</li></ul>
</td></tr>
<tr><td><code id="prms_+3A_nsim">nsim</code></td>
<td>
<p>(Optional) The number of total simulations to be conducted. Defaults to 1,000.</p>
</td></tr>
<tr><td><code id="prms_+3A_ncores">ncores</code></td>
<td>
<p>(Optional) The number of CPU cores to use for parallel processing (OpenMP). If R hasn't been installed with OpenMP configured, this will not take effect. When OpenMP is available, it should not exceed the number of existing cores. If unspecified, it will default to 2 cores or the number of existing cores, whichever is smaller.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>A list of lists
</p>

<ul>
<li> <p><code>parameters</code> - A list of true parameter settings.
</p>
</li>
<li> <p><code>passing_rate</code> - The estimated passing rate.
</p>
</li>
<li> <p><code>runtime</code> - The total elapsed time charged for the execution of the program.
</p>
</li></ul>



<h3>Author(s)</h3>

<p>Daeyoung Lim, <a href="mailto:daeyoung.lim@uconn.edu">daeyoung.lim@uconn.edu</a>
</p>


<h3>References</h3>

<p>Davit, B. M., Chen, M. L., Conner, D. P., Haidar, S. H., Kim, S., Lee, C. H., Lionberger, R. A., Makhlouf, F. T., Nwakama, P. E., Patel, D. T., Schuirmann, D. J., &amp; Yu, L. X. (2012). Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. The AAPS journal, 14(4), 915-924.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>out &lt;- prms(10, 6, nsim = 2)

</code></pre>

<hr>
<h2 id='PRsurface'>Plot the passing-rate curve and the passing-rate surface in IVPT</h2><span id='topic+PRsurface'></span>

<h3>Description</h3>

<p>This function plots the power (passing-rate) curve and power (passing-rate) surface of the mixed scaling (MS) approach. A power curve shows the statistical power across different effect sizes. In IVPT studies, the effect size is captured by the difference between the means of log-measurements of the test and reference products (i.e., logGMR). For the passing-rate surface, the corresponding function considers different values of the standard deviation.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>PRsurface(
  n,
  r,
  observed_GMR = 0.95,
  observed_sigmaWR = 0.294,
  GMR_grid = seq(0.75, 1.3, length.out = 100),
  sigmaWR_grid = seq(0.2, 1, length.out = 100),
  params = list(),
  nsim = 1000,
  ncores = NULL,
  verbose = FALSE,
  plot = TRUE
)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="PRsurface_+3A_n">n</code></td>
<td>
<p>The number of donors in each simulation.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_r">r</code></td>
<td>
<p>The number of replicates from each donor for each simulated dataset.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_observed_gmr">observed_GMR</code></td>
<td>
<p>The observed (estimated) GMR of the user's data. Along with the observed sigmaWR, the corresponding passing rate will be displayed in the 3D plot as a vertical line parallel to the z-axis.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_observed_sigmawr">observed_sigmaWR</code></td>
<td>
<p>The observed (estimated) sigmaWR of the user's data. Along with the observed GMR, the corresponding passing rate will be displayed in the 3D plot as a vertical line parallel to the z-axis.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_gmr_grid">GMR_grid</code></td>
<td>
<p>The grid of GMR values to be used for plotting the 3D surface of passing rates.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_sigmawr_grid">sigmaWR_grid</code></td>
<td>
<p>The grid of sigmaWR values to be used for plotting the 3D surface of passing rates.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_params">params</code></td>
<td>
<p>(Optional) The list of true parameters to be assumed in data generation.
</p>

<ul>
<li> <p><code>sigma_W0</code> - A regulatory constant set by the FDA. Defaults to 0.25.
</p>
</li>
<li> <p><code>sigma_WT</code> - The true standard deviation of the test formulation population.
</p>
</li>
<li> <p><code>sigma_WR</code> - The true standard deviation of the reference formulation population.
</p>
</li>
<li> <p><code>GMR</code> - The geometric mean ratio of the test and reference values of the pharmacokinetic measures (e.g., Jmax or AUC). If the test-formulation measure is greater than that of the reference formulation, then GMR is typically set to 1.05, which is the initial value of this function. If the reference-formulation measure is bigger, then GMR is typically 0.95. Defaults to 0.95.
</p>
</li>
<li> <p><code>m</code> - Another regulatory constant that determines the bounds within which the estimated GMR should fall for bioequivalence to be established. Defaults to 1.25, representing 80-125% average BE limits, which is the FDA recommendation.
</p>
</li>
<li> <p><code>sig_level</code> - The significance level (alpha-level). Defaults to 0.05.
</p>
</li></ul>
</td></tr>
<tr><td><code id="PRsurface_+3A_nsim">nsim</code></td>
<td>
<p>(Optional) The number of total simulations to be conducted. Defaults to 1,000.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_ncores">ncores</code></td>
<td>
<p>(Optional) The number of CPU cores to use for parallel processing (OpenMP). If R hasn't been installed with OpenMP configured, this will not take effect. When OpenMP is available, it should not exceed the number of existing cores. If unspecified, it will default to 2 cores or the number of existing cores, whichever is smaller.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_verbose">verbose</code></td>
<td>
<p>(Optional) A logical value (<code>TRUE</code>/<code>FALSE</code>) indicating whether to display the progress bar.</p>
</td></tr>
<tr><td><code id="PRsurface_+3A_plot">plot</code></td>
<td>
<p>(Optional) A logical value (<code>TRUE</code>/<code>FALSE</code>) indicating whether to generate a 3D interactive plot of the surface. If <code>FALSE</code>, the function will return the (x, y, z) values as a <code>list</code>.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>A list
</p>

<ul>
<li> <p><code>GMR</code> - A list of true parameter settings.
</p>
</li>
<li> <p><code>passing_rate</code> - The estimated passing rate.
</p>
</li>
<li> <p><code>runtime</code> - The total elapsed time charged for the execution of the program.
</p>
</li></ul>



<h3>Author(s)</h3>

<p>Daeyoung Lim, <a href="mailto:daeyoung.lim@uconn.edu">daeyoung.lim@uconn.edu</a>
</p>


<h3>References</h3>

<p>Davit, B. M., Chen, M. L., Conner, D. P., Haidar, S. H., Kim, S., Lee, C. H., Lionberger, R. A., Makhlouf, F. T., Nwakama, P. E., Patel, D. T., Schuirmann, D. J., &amp; Yu, L. X. (2012). Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. The AAPS journal, 14(4), 915-924.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>out &lt;- PRsurface(6, 3, GMR_grid = c(0.90, 1), sigmaWR_grid = c(0.2, 0.5), nsim = 2, plot = FALSE)

</code></pre>

<hr>
<h2 id='rss'>Reestimate the sample size for the adaptive design in bioequivalence (BE) studies using mixed criterion.</h2><span id='topic+rss'></span>

<h3>Description</h3>

<p>This function reestimates the sample size using mixed criterion required for target power, using binary search. The power (passing rate) function of mixed criterion testing lacks a closed-form expression. Thus, sample size (re-)estimation requires a binary search, after identifying an <code>n</code> where the passing rate exceeds the desired level.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>rss(n, r, S_WR, params = list(), nsim = 1000, ncores = NULL)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="rss_+3A_n">n</code></td>
<td>
<p>The number of donors in each simulation.</p>
</td></tr>
<tr><td><code id="rss_+3A_r">r</code></td>
<td>
<p>The number of replicates from each donor for each simulated dataset.</p>
</td></tr>
<tr><td><code id="rss_+3A_s_wr">S_WR</code></td>
<td>
<p>The estimated standard deviation of the reference measurements. The reference-scaled average bioequivalence approach is used if S_WR &gt; 0.249 and the average bioequivalence approach otherwise.</p>
</td></tr>
<tr><td><code id="rss_+3A_params">params</code></td>
<td>
<p>(Optional) The list of true parameters to be assumed in data generation.
</p>

<ul>
<li> <p><code>sigma_W0</code> - A regulatory constant set by the FDA. Defaults to 0.25.
</p>
</li>
<li> <p><code>GMR</code> - The geometric mean ratio of the test and reference values of the pharmacokinetic measures (e.g., Jmax or AUC). If the test-formulation measure is greater than that of the reference formulation, then GMR is typically set to 1.05, which is the initial value of this function. If the reference-formulation measure is bigger, then GMR is typically 0.95. Defaults to 0.95.
</p>
</li>
<li> <p><code>m</code> - Another regulatory constant that determines the bounds within which the estimated GMR should fall for bioequivalence to be established. Defaults to 1.25, representing 80-125% average BE limits, which is the FDA recommendation.
</p>
</li>
<li> <p><code>sig_level</code> - The significance level (alpha-level).
</p>
</li>
<li> <p><code>nmax</code> - The upper limit for sample size reestimation. If the sample size exceeds <code>nmax</code> inside estimation procedure, the function will return <code>nmax</code>.
</p>
</li>
<li> <p><code>target_power</code> - The threshold for power (or passing rate) for a hypothesis test to be considered powerful. Typically set at 80% and defaults to 0.8.
</p>
</li></ul>
</td></tr>
<tr><td><code id="rss_+3A_nsim">nsim</code></td>
<td>
<p>(Optional) The number of total simulations to be conducted. Defaults to 1,000.</p>
</td></tr>
<tr><td><code id="rss_+3A_ncores">ncores</code></td>
<td>
<p>(Optional) The number of CPU cores to use for parallel processing (OpenMP). If R hasn't been installed with OpenMP configured, this will not take effect. When OpenMP is available, it should not exceed the number of existing cores. If unspecified, it will default to 2 cores or the number of existing cores, whichever is smaller.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>A list of lists
</p>

<ul>
<li> <p><code>parameters</code> - A list of true parameter settings.
</p>
</li>
<li> <p><code>rss</code> - The reestimated sample size.
</p>
</li>
<li> <p><code>runtime</code> - The total elapsed time charged for the execution of the program.
</p>
</li></ul>



<h3>Author(s)</h3>

<p>Daeyoung Lim, <a href="mailto:daeyoung.lim@uconn.edu">daeyoung.lim@uconn.edu</a>
</p>


<h3>References</h3>

<p>Potvin, D., DiLiberti, C. E., Hauck, W. W., Parr, A. F., Schuirmann, D. J., &amp; Smith, R. A. (2008). Sequential design approaches for bioequivalence studies with crossover designs. Pharmaceutical Statistics: The Journal of Applied Statistics in the Pharmaceutical Industry, 7(4), 245-262.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>out &lt;- rss(10, 6, S_WR = 0.22, nsim = 2)

</code></pre>

<hr>
<h2 id='summary.msabe'>'summary' method for class &quot;'msabe'&quot;</h2><span id='topic+summary.msabe'></span>

<h3>Description</h3>

<p>'summary' method for class &quot;'msabe'&quot;
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'msabe'
summary(object, ...)
</code></pre>


<h3>Arguments</h3>

<table role = "presentation">
<tr><td><code id="summary.msabe_+3A_object">object</code></td>
<td>
<p>an output from 'msabe'</p>
</td></tr>
<tr><td><code id="summary.msabe_+3A_...">...</code></td>
<td>
<p>additional arguments for print</p>
</td></tr>
</table>


<h3>Value</h3>

<p>Does not return anything; print a summary of the output
</p>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
